These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8349581

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
    Ofosu FA, Fenton JW, Maraganore J, Blajchman MA, Yang X, Smith L, Anvari N, Buchanan MR, Hirsh J.
    Biochem J; 1992 May 01; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
    [Abstract] [Full Text] [Related]

  • 24. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V, Zingali RB, Guillin MC, Bon C, Jandrot-Perrus M.
    Biochemistry; 1996 Jul 16; 35(28):9083-9. PubMed ID: 8703912
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Conformational transitions linked to active site ligation in human thrombin: effect on the interaction with fibrinogen and the cleavable platelet receptor.
    De Cristofaro R, De Candia E, Picozzi M, Landolfi R.
    J Mol Biol; 1995 Jan 27; 245(4):447-58. PubMed ID: 7837275
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen.
    Ni F, Konishi Y, Frazier RB, Scheraga HA, Lord ST.
    Biochemistry; 1989 Apr 04; 28(7):3082-94. PubMed ID: 2742826
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Expression of allosteric linkage between the sodium ion binding site and exosite I of thrombin during prothrombin activation.
    Kroh HK, Tans G, Nicolaes GA, Rosing J, Bock PE.
    J Biol Chem; 2007 Jun 01; 282(22):16095-104. PubMed ID: 17430903
    [Abstract] [Full Text] [Related]

  • 34. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY.
    Biochemistry; 1991 Jul 09; 30(27):6656-61. PubMed ID: 2065053
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II.
    Hortin GL, Tollefsen DM, Benutto BM.
    J Biol Chem; 1989 Aug 25; 264(24):13979-82. PubMed ID: 2760054
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V, Colombo G, Russo I, Spadari B, Fontana A.
    Biochemistry; 2002 Nov 19; 41(46):13556-69. PubMed ID: 12427016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.